• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种不同溶瘤病毒(呼肠孤病毒和兔粘液瘤病毒)的病毒趋向性受细胞肿瘤抑制基因状态的调节。

The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.

机构信息

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.

出版信息

Oncogene. 2010 Jul 8;29(27):3990-6. doi: 10.1038/onc.2010.137. Epub 2010 May 17.

DOI:10.1038/onc.2010.137
PMID:20473328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4374435/
Abstract

Replication-competent oncolytic viruses hold great potential for the clinical treatment of many cancers. Importantly, many oncolytic virus candidates, such as reovirus and myxoma virus, preferentially infect cancer cells bearing abnormal cellular signaling pathways. Reovirus and myxoma virus are highly responsive to activated Ras and Akt signaling pathways, respectively, for their specificity for viral oncolysis. However, considering the complexity of cancer cell populations, it is possible that other tumor-specific signaling pathways may also contribute to viral discrimination between normal versus cancer cells. Because carcinogenesis is a multistep process involving the accumulation of both oncogene activations and the inactivation of tumor suppressor genes, we speculated that not only oncogenes but also tumor suppressor genes may have an important role in determining the tropism of these viruses for cancer cells. It has been previously shown that many cellular tumor suppressor genes, such as p53, ATM and Rb, are important for maintaining genomic stability; dysfunction of these tumor suppressors may disrupt intact cellular antiviral activity due to the accumulation of genomic instability or due to interference with apoptotic signaling. Therefore, we speculated that cells with dysfunctional tumor suppressors may display enhanced susceptibility to challenge with these oncolytic viruses, as previously seen with adenovirus. We report here that both reovirus and myxoma virus preferentially infect cancer cells bearing dysfunctional or deleted p53, ATM and Rb tumor suppressor genes compared to cells retaining normal counterparts of these genes. Thus, oncolysis by these viruses may be influenced by both oncogenic activation and tumor suppressor status.

摘要

复制型溶瘤病毒在许多癌症的临床治疗中有很大的应用潜力。重要的是,许多溶瘤病毒候选物,如呼肠孤病毒和兔粘液瘤病毒,优先感染携带异常细胞信号通路的癌细胞。呼肠孤病毒和兔粘液瘤病毒对激活的 Ras 和 Akt 信号通路分别高度敏感,是它们对病毒溶瘤作用的特异性。然而,考虑到癌细胞群体的复杂性,其他肿瘤特异性信号通路也可能有助于病毒区分正常细胞和癌细胞。由于癌变是一个多步骤的过程,涉及癌基因的激活和肿瘤抑制基因的失活,我们推测不仅癌基因,而且肿瘤抑制基因可能在决定这些病毒对癌细胞的亲嗜性方面发挥重要作用。先前已经表明,许多细胞肿瘤抑制基因,如 p53、ATM 和 Rb,对于维持基因组稳定性很重要;这些肿瘤抑制因子的功能障碍可能会由于基因组不稳定性的积累或由于干扰凋亡信号而破坏完整的细胞抗病毒活性。因此,我们推测,具有功能失调的肿瘤抑制因子的细胞可能对这些溶瘤病毒的挑战表现出增强的易感性,就像以前腺病毒所看到的那样。我们在这里报告,呼肠孤病毒和兔粘液瘤病毒优先感染携带功能失调或缺失的 p53、ATM 和 Rb 肿瘤抑制基因的癌细胞,而不是保留这些基因正常拷贝的细胞。因此,这些病毒的溶瘤作用可能受到致癌激活和肿瘤抑制状态的影响。

相似文献

1
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.两种不同溶瘤病毒(呼肠孤病毒和兔粘液瘤病毒)的病毒趋向性受细胞肿瘤抑制基因状态的调节。
Oncogene. 2010 Jul 8;29(27):3990-6. doi: 10.1038/onc.2010.137. Epub 2010 May 17.
2
Replicating poxviruses for human cancer therapy.用于人类癌症治疗的痘病毒复制
J Microbiol. 2015 Apr;53(4):209-18. doi: 10.1007/s12275-015-5041-4. Epub 2015 Apr 8.
3
Naturally occurring reoviruses for human cancer therapy.用于人类癌症治疗的天然呼肠孤病毒。
BMB Rep. 2015 Aug;48(8):454-60. doi: 10.5483/bmbrep.2015.48.8.076.
4
Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis.化疗药物激活 p53 增强呼肠孤病毒的溶瘤作用。
PLoS One. 2013;8(1):e54006. doi: 10.1371/journal.pone.0054006. Epub 2013 Jan 16.
5
Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene.缺乏serp2基因的黏液瘤病毒对犬肿瘤细胞的溶瘤作用。
Am J Vet Res. 2012 Aug;73(8):1252-61. doi: 10.2460/ajvr.73.8.1252.
6
Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.核磷蛋白抑制致癌基因诱导的细胞凋亡和衰老,并增强基因组不稳定细胞中的致癌协同作用。
Carcinogenesis. 2007 Jun;28(6):1163-70. doi: 10.1093/carcin/bgm025. Epub 2007 Feb 2.
7
E1B55K-deleted adenovirus (ONYX-015) overrides G1/S and G2/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells.缺失E1B55K的腺病毒(ONYX-015)可绕过G1/S和G2/M检查点,并在p53功能正常的正常细胞中引发有丝分裂灾难和核内复制。
Cell Cycle. 2006 Oct;5(19):2244-52. doi: 10.4161/cc.5.19.3263. Epub 2006 Oct 1.
8
Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.解除呼肠孤病毒溶瘤、Ras信号传导、翻译控制与癌症之间的联系。
Oncogene. 2005 Nov 21;24(52):7720-8. doi: 10.1038/sj.onc.1209041.
9
Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release.溶瘤呼肠孤病毒诱导Ras在细胞内重新分布以促进细胞凋亡和子代病毒释放。
Oncogene. 2016 Feb 11;35(6):771-82. doi: 10.1038/onc.2015.136. Epub 2015 May 11.
10
Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.溶瘤病毒疗法与信号抑制剂的协同作用:雷帕霉素增强黏液瘤病毒对人肿瘤细胞的嗜性。
J Virol. 2007 Feb;81(3):1251-60. doi: 10.1128/JVI.01408-06. Epub 2006 Nov 15.

引用本文的文献

1
The reovirus variant RP116 is oncolytic in immunocompetent models and generates reduced neutralizing antibodies to Type 3 Dearing.呼肠孤病毒变体RP116在免疫活性模型中具有溶瘤性,并且产生针对3型迪林毒株的中和抗体减少。
Mol Ther Oncol. 2024 Jun 29;32(3):200846. doi: 10.1016/j.omton.2024.200846. eCollection 2024 Sep 19.
2
Cytokine Gene Vaccine Therapy for Treatment of a Brain Tumor.细胞因子基因疫苗疗法治疗脑肿瘤
Brain Sci. 2023 Oct 25;13(11):1505. doi: 10.3390/brainsci13111505.
3
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma.IDH1 突变会损害抗病毒反应,并增强溶瘤病毒疗法在神经胶质瘤中的作用。
Nat Commun. 2023 Oct 25;14(1):6781. doi: 10.1038/s41467-023-42545-3.
4
Optimal delivery of RNA interference by viral vectors for cancer therapy.病毒载体介导的 RNA 干扰在癌症治疗中的最佳传递。
Mol Ther. 2023 Nov 1;31(11):3127-3145. doi: 10.1016/j.ymthe.2023.09.012. Epub 2023 Sep 20.
5
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer.核输出抑制剂 Selinexor 增强溶瘤性牛痘病毒治疗癌症。
Cancer Res Commun. 2023 Jun 1;3(6):952-968. doi: 10.1158/2767-9764.CRC-22-0483. eCollection 2023 Jun.
6
Oncolytic virus therapy in cancer: A current review.癌症中的溶瘤病毒疗法:当前综述
World J Virol. 2021 Sep 25;10(5):229-255. doi: 10.5501/wjv.v10.i5.229.
7
RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells.RNA 解旋酶 A/DHX9 形成独特的细胞质抗病毒颗粒,限制溶瘤性兔病毒性出血热病毒在人癌细胞中的复制。
J Virol. 2021 Jun 24;95(14):e0015121. doi: 10.1128/JVI.00151-21.
8
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs.溶瘤病毒与血液系统恶性肿瘤:一类新型免疫治疗药物。
Curr Oncol. 2020 Dec 25;28(1):159-183. doi: 10.3390/curroncol28010019.
9
Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1.在工程化溶瘤单纯疱疹病毒1型中共同表达白细胞介素-12和粒细胞巨噬细胞集落刺激因子的抗肿瘤作用
Gene Ther. 2021 Apr;28(3-4):186-198. doi: 10.1038/s41434-020-00205-x. Epub 2020 Nov 4.
10
Oncolytic virotherapy in hepato-bilio-pancreatic cancer: The key to breaking the log jam?肝胰胆癌的溶瘤病毒疗法:打破僵局的关键?
Cancer Med. 2020 May;9(9):2943-2959. doi: 10.1002/cam4.2949. Epub 2020 Mar 4.

本文引用的文献

1
Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells.黏液瘤病毒靶向原发性人类白血病干细胞和祖细胞,同时不影响正常造血干细胞和祖细胞。
Leukemia. 2009 Dec;23(12):2313-7. doi: 10.1038/leu.2009.219. Epub 2009 Oct 29.
2
Activated Ras signaling significantly enhances reovirus replication and spread.激活的Ras信号通路显著增强呼肠孤病毒的复制和传播。
Cancer Gene Ther. 2010 Jan;17(1):69-70. doi: 10.1038/cgt.2009.46.
3
Induction of alpha/beta interferon by myxoma virus is selectively abrogated when primary mouse embryo fibroblasts become immortalized.当原代小鼠胚胎成纤维细胞永生化时,黏液瘤病毒对α/β干扰素的诱导作用会被选择性消除。
J Virol. 2009 Jun;83(11):5928-32. doi: 10.1128/JVI.02587-08. Epub 2009 Mar 18.
4
Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.通过整合高分辨率全基因组分析揭示套细胞淋巴瘤中的单亲二体、纯合缺失、扩增及靶基因
Blood. 2009 Mar 26;113(13):3059-69. doi: 10.1182/blood-2008-07-170183. Epub 2008 Nov 4.
5
A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer.一项关于晚期癌症患者静脉注射3型迪尔林溶瘤呼肠孤病毒的I期研究。
Clin Cancer Res. 2008 Nov 1;14(21):7127-37. doi: 10.1158/1078-0432.CCR-08-0524.
6
Reovirus infection of cancer cells is not due to activated Ras pathway.癌细胞的呼肠孤病毒感染并非由于Ras信号通路激活所致。
Cancer Gene Ther. 2009 Apr;16(4):382. doi: 10.1038/cgt.2008.84. Epub 2008 Oct 24.
7
Transcriptional role of p53 in interferon-mediated antiviral immunity.p53在干扰素介导的抗病毒免疫中的转录作用。
J Exp Med. 2008 Aug 4;205(8):1929-38. doi: 10.1084/jem.20080383. Epub 2008 Jul 28.
8
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.一项针对组织学确诊的复发性恶性胶质瘤患者进行瘤内注射呼肠孤病毒的I期试验。
Mol Ther. 2008 Mar;16(3):627-32. doi: 10.1038/sj.mt.6300403. Epub 2008 Feb 5.
9
Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.肿瘤抑制因子p53在宿主抗丙型肝炎病毒防御中的潜在作用。
Hepatology. 2008 Apr;47(4):1136-49. doi: 10.1002/hep.22176.
10
Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.黏液瘤病毒对原发性和转移性B16F10小鼠肿瘤的体内溶瘤作用。
Mol Ther. 2008 Jan;16(1):52-9. doi: 10.1038/sj.mt.6300348. Epub 2007 Nov 13.